Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech innovator, announced its inclusion in an editorial by NetworkNewsWire titled“ ...

Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech firm developing targeted therapies for genetic medicine delivery, announced a ...

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...

CLDI Stock- Calidi Biotherapeutics raises $4.6M via discounted warrants to fund clinical programs and extend operational ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies.

Complete Calidi Biotherapeutics Inc. stock information by Barron's. View real-time CLDI stock price and news, along with industry-best analysis.

OrganOx Ltd., a leading organ medical technology company, has been announced as the winner of the prestigious 2025 MacRobert Award by the Royal Academy of Engineering.

U.S. crude oil inventories increased by 7.070 million barrels in the week ended July 4, recording the biggest gain since ...

Calidi Biotherapeutics stock was up 171.84% in pre-market trading on Wednesday, following a 39.47% rally yesterday. However, ...

NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the ...